These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31215655)

  • 1. The effect of insights on medication adherence in patients with schizophrenia.
    Kalkan E; Kavak Budak F
    Perspect Psychiatr Care; 2020 Jan; 56(1):222-228. PubMed ID: 31215655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of adherence to antipsychotics medication on the quality of life among patients with schizophrenia in Indonesia.
    Endriyani L; Chien CH; Huang XY; Chieh-Yu L
    Perspect Psychiatr Care; 2019 Apr; 55(2):147-152. PubMed ID: 29578605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of mindfulness-based psychoeducation on insight and medication adherence of schizophrenia patients.
    Çetin N; Aylaz R
    Arch Psychiatr Nurs; 2018 Oct; 32(5):737-744. PubMed ID: 30201202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Adherence Therapy for People With Schizophrenia in Turkey: A Controlled Study.
    Dikec G; Kutlu Y
    Arch Psychiatr Nurs; 2016 Apr; 30(2):249-56. PubMed ID: 26992879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.
    Beck EM; Cavelti M; Kvrgic S; Kleim B; Vauth R
    Schizophr Res; 2011 Oct; 132(1):42-9. PubMed ID: 21820875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictors of medication non-adherence among a Moroccan sample of patients with schizophrenia: A cross sectional study].
    El Ammouri A; Kisra H
    Encephale; 2017 Dec; 43(6):522-527. PubMed ID: 27663045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight and medication adherence in schizophrenia: An analysis of the CATIE trial.
    Kim J; Ozzoude M; Nakajima S; Shah P; Caravaggio F; Iwata Y; De Luca V; Graff-Guerrero A; Gerretsen P
    Neuropharmacology; 2020 May; 168():107634. PubMed ID: 31077729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic medication adherence and satisfaction among Palestinian people with schizophrenia.
    Sweileh WM; Ihbesheh MS; Jarar IS; Sawalha AF; Abu Taha AS; Zyoud SH; Morisky DE
    Curr Clin Pharmacol; 2012 Feb; 7(1):49-55. PubMed ID: 22299769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: a cross sectional study.
    Bressington D; Mui J; Gray R
    Int J Ment Health Nurs; 2013 Feb; 22(1):35-46. PubMed ID: 22738372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study.
    Brain C; Allerby K; Sameby B; Quinlan P; Joas E; Karilampi U; Lindström E; Eberhard J; Burns T; Waern M
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1754-62. PubMed ID: 24091164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring predictors of medication adherence among inpatients with schizophrenia in Singapore's mental health settings: A non-experimental study.
    Tham XC; Xie H; Chng CML; Seah XY; Lopez V; Klainin-Yobas P
    Arch Psychiatr Nurs; 2018 Aug; 32(4):536-548. PubMed ID: 30029745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability and validity of the Medication Adherence Rating Scale in a cohort of patients with schizophrenia from Nigeria.
    Owie GO; Olotu SO; James BO
    Trends Psychiatry Psychother; 2018; 40(2):85-92. PubMed ID: 29768528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia.
    Eticha T; Teklu A; Ali D; Solomon G; Alemayehu A
    PLoS One; 2015; 10(3):e0120560. PubMed ID: 25816353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early perception of medication benefit predicts subsequent antipsychotic response in schizophrenia: "the consumer has a point" revisited.
    Ascher-Svanum H; Weiden P; Nyhuis AW; Faries DE; Stauffer V; Kollack-Walker S; Kinon BJ
    Clin Schizophr Relat Psychoses; 2014 Jul; 8(2):84-90, 90A. PubMed ID: 23446198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships among medication adherence, insight, and neurocognition in chronic schizophrenia.
    Na E; Yim SJ; Lee JN; Kim JM; Hong K; Hong MH; Han H
    Psychiatry Clin Neurosci; 2015 May; 69(5):298-304. PubMed ID: 25600955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Denial and acceptance coping styles and medication adherence in schizophrenia.
    Aldebot S; de Mamani AG
    J Nerv Ment Dis; 2009 Aug; 197(8):580-4. PubMed ID: 19684494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mediating effect of family function and medication adherence between symptoms and mental disability among Chinese patients with schizophrenia: a cross-sectional study.
    Sun Y; Wang M; Zhou Y; Wang L; Zhang H; Lv Y; Li G
    Psychol Health Med; 2019 Jun; 24(5):559-569. PubMed ID: 30332286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia and medication adherence: Associated factors.
    Karabulut B; Uslu E
    Arch Psychiatr Nurs; 2024 Apr; 49():47-54. PubMed ID: 38734454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Paliperidone Palmitate and Second-Generation Oral Antipsychotics in Terms of Medication Adherence, Side Effects, and Quality of Life.
    Sağlam Aykut D
    J Clin Psychopharmacol; 2019; 39(1):57-62. PubMed ID: 30566417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.